Experience of effective treatment for patients with severe psoriasis | Zendy

Nikolay V. Kungurov | Zendy; Н. В. Зильберберг | Zendy; М. М. Кохан | Zendy; J. V. Keniksfest | Zendy; J M ZASADKEVICH | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Experience of effective treatment for patients with severe psoriasis

Author(s) -

Nikolay V. Kungurov,

Н. В. Зильберберг,

М. М. Кохан,

J. V. Keniksfest,

J M ZASADKEVICH

Publication year - 2012

Publication title -

vestnik dermatologii i venerologii

Language(s) - English

Resource type - Journals

eISSN - 2313-6294

pISSN - 0042-4609

DOI - 10.25208/vdv653

Subject(s) - ustekinumab , psoriasis , medicine , adverse effect , quality of life (healthcare) , dermatology , disease , adalimumab , nursing

In this study was summarized the clinical monitoring of 6 patients with a vulgar severe psoriasis receiving a short course of Ustekinumab — antagonist of IL 12/23. Clinical monitoring demonstrated high efficiency of treatment with achievement of clinical remission and appreciable improvement in all patients; conservation of remission of psoriasis process till 6 months with regress of PASI more than 75 % from initial point in 5 from 6 patients; improvement of quality of life, absence of complications and adverse events during the treatment and the subsequent observation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research